Watson Launches Overactive Bladder Gel
Links shared publicly online about this topic
FDA OKs First Overactive Bladder Gel Gelnique
webmd.com — “The FDA has approved Gelnique, the first and only topical gel to treat overactive bladder.” View full resource at webmd.com
Most Recently Shared on February 6, 2010 at 6:31 pm By:
FDA OKs First Overactive Bladder Gel Gelnique - http://short.to/164t7 #urinaryincontinence
First and Only Topical Gel for Overactive Bladder Cleared - Renal and Urology News
renalandurologynews.com — “Watson Pharmaceuticals, Corona, Calif., has received approval for Gelnique (oxybutynin chloride) Gel 10%, the first and only topical gel for the treatment of overactive bladder (OAB).” View full resource at renalandurologynews.com
Most Recently Shared on July 23, 2009 at 8:48 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
First and Only Topical Gel for Overactive Bladder Cleared: Watson Pharmaceuticals, Corona, Calif., has received .. http://bit.ly/M3jm0
Gelnique gel available for overactive bladder (OAB) - MPR
empr.com — “Gelnique gel (oxybutynin chloride 10%) has been made available by Watson as a once-daily topical treatment for overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency.” View full resource at empr.com
Most Recently Shared on May 21, 2009 at 3:21 pm By:
MPR News: Gelnique gel available for overactive bladder (OAB): Gelnique gel (oxybutynin chloride 10%) h.. http://tinyurl.com/o4lokr
Medical News: Topical Gel Approved for Overactive Bladder - in Urology, General Urology from MedPage Today
medpagetoday.com — “CORONA, Calif., Jan. 28 -- The FDA has okayed oxybutynin chloride gel 10% (Gelnique) for the treatment of overactive bladder, Watson Pharmaceuticals announced.” View full resource at medpagetoday.com
Most Recently Shared on January 28, 2009 at 8:12 pm By:
Topical Gel Approved for Overactive Bladder http://medpagetoday.com/12642
FDA approves topical gel for OAB - - ModernMedicine
modernmedicine.com — “Watson Pharmaceuticals, Inc., and Antares Pharma, Inc., recently announced the FDA approval of Antares? topical oxybutynin gel 3% for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.” View full resource at modernmedicine.com
Most Recently Shared on December 22, 2011 at 9:21 pm By:
FDA approves topical gel for OAB: Watson Pharmaceuticals, Inc., and Antares Pharma, Inc., recently announced the... http://t.co/7YPCEac9
Phase 3 results of Gelnique for female overactive bladder - MPR
empr.com — “Watson Pharmaceuticals announced results of its Phase 3 study of Gelnique (oxybutynin chloride) 10% gel for the treatment of women with overactive bladder (OAB) and urinary urge incontinence.” View full resource at empr.com
Most Recently Shared on April 28, 2009 at 9:07 pm By:
MPR News: Phase 3 results of Gelnique for female overactive bladder: Watson Pharmaceuticals announced r.. http://tinyurl.com/ccwhtl
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Wet Matters
Elizabeth Houser, MD and Stephanie Riley Hahn, PT - two gals on a mission to help women with urinary incontinence. Helpful resources at wetmatters.com.
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
